The insulin/IGF-like signaling is widely accepted as a signaling pathway that plays a central role in the regulation of organism growth and lifespan.
Lipid metabolism has now been accepted as a major metabolic pathway that is involved in many aspects of cancer cell biology.
28 This document provides a section focused on circumstances in which limited clinical data may be accepted and describes pathways that are effectively identical to the Tier B and C concepts discussed above.
Indeed, it is well accepted that MLCP can be inhibited via a pathway that involves RhoA/ROCK signaling.
It is that connection, that pathway, that has been lost.
Interestingly, a number of mutations (PIK3CA, CDKN2A and APC) do not fit within the pathways that are widely accepted to underlie UCC (illustrated in Fig. 1).
A certain amount of variation is accepted, so that pathways can be tailored for particular purposes and creative solutions can be developed for managing the interdependencies of their components in particular circumstances [ 30].
It is well accepted that ROS signalling controls fat cell formation in vitro; the pathways that govern this process, however, are still incompletely understood.
Surprisingly, the authors used the XR/XDH pathway, although it is generally accepted that the XI pathway is more favorable for yeast (Biotechnol Biofuels, 2013, 6, 89; Metab Eng., 2012, 14: 614-22).
